1. Home
  2. TEVA vs RPM Comparison

TEVA vs RPM Comparison

Compare TEVA & RPM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TEVA
  • RPM
  • Stock Information
  • Founded
  • TEVA 1901
  • RPM 1947
  • Country
  • TEVA Israel
  • RPM United States
  • Employees
  • TEVA N/A
  • RPM N/A
  • Industry
  • TEVA Biotechnology: Pharmaceutical Preparations
  • RPM Paints/Coatings
  • Sector
  • TEVA Health Care
  • RPM Consumer Discretionary
  • Exchange
  • TEVA Nasdaq
  • RPM Nasdaq
  • Market Cap
  • TEVA 19.2B
  • RPM 17.4B
  • IPO Year
  • TEVA N/A
  • RPM N/A
  • Fundamental
  • Price
  • TEVA $21.94
  • RPM $125.85
  • Analyst Decision
  • TEVA Buy
  • RPM Buy
  • Analyst Count
  • TEVA 7
  • RPM 10
  • Target Price
  • TEVA $21.00
  • RPM $133.40
  • AVG Volume (30 Days)
  • TEVA 11.9M
  • RPM 648.4K
  • Earning Date
  • TEVA 01-29-2025
  • RPM 01-07-2025
  • Dividend Yield
  • TEVA N/A
  • RPM 1.63%
  • EPS Growth
  • TEVA N/A
  • RPM 20.17
  • EPS
  • TEVA N/A
  • RPM 4.77
  • Revenue
  • TEVA $16,772,000,000.00
  • RPM $7,292,209,000.00
  • Revenue This Year
  • TEVA $4.70
  • RPM $2.03
  • Revenue Next Year
  • TEVA $4.47
  • RPM $3.82
  • P/E Ratio
  • TEVA N/A
  • RPM $26.27
  • Revenue Growth
  • TEVA 9.81
  • RPM N/A
  • 52 Week Low
  • TEVA $10.34
  • RPM $100.82
  • 52 Week High
  • TEVA $22.17
  • RPM $141.79
  • Technical
  • Relative Strength Index (RSI)
  • TEVA 75.93
  • RPM 27.15
  • Support Level
  • TEVA $16.25
  • RPM $131.13
  • Resistance Level
  • TEVA $21.98
  • RPM $134.23
  • Average True Range (ATR)
  • TEVA 0.79
  • RPM 2.51
  • MACD
  • TEVA 0.53
  • RPM -1.46
  • Stochastic Oscillator
  • TEVA 90.58
  • RPM 7.86

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

About RPM RPM International Inc.

RPM International Inc manufactures and sells a variety of paints, coatings, and adhesives. The firm organizes itself into four segments based on product type. The construction products group sells coatings, roofing, insulation, and other products to distributors, contractors, and end consumers globally. The performance coatings group produces coatings that are used in construction and industrial applications like floorings and corrosion control. The consumer group sells paint, finishes, and similar products to individual consumers through hardware and craft stores. The specialty products group sells a line of products ranging from niche applications of the other groups to marine finishes, to edible food colorings. The majority of revenue comes from North America.

Share on Social Networks: